Literature DB >> 32909200

Clear colonoscopy as a surveillance tool in the prediction and reduction of advanced neoplasms: a randomized controlled trial.

Qisheng Zhang1, Yucui Shen2, Jianhua Xu2, Peng Gao2.   

Abstract

BACKGROUND: Missed and incompletely resected lesions remain the main cause of the recurrence of advanced neoplasms (ANs) in post-polypectomy patients. This study aims to determine whether the recurrence of ANs can be predicted and reduced by the newly developed clear colonoscopy procedure.
METHODS: Between 2006 and 2010, a total of 1350 participants with colorectal neoplasm were equally randomized to clear colonoscopy surveillance (CCS) and routine colonoscopy surveillance (RCS) in our center. Clear colonoscopy was achieved through repeat colonoscopy. On surveillance colonoscopy at 3 (for high-risk patients) and 5 (for low-risk patients) years, the recurrence of ANs and the relationship between the frequency of repeat examinations required for a clear colonoscopy and the recurrence of ANs were analyzed.
RESULTS: Surveillance colonoscopy at 3 and 5 years showed that the incidence of ANs in patients belonging to the CCS group was 1.7%, which was lower than 4.7% in patients belonging to the RCS group (P = 0.012) for both high- and low-risk patients. Out of the 1126 patients who achieved clear colonoscopy on first repeat examination, only 5 ( 0.4%) were found to have ANs on surveillance examination, whereas 12 out of the 217 (5.4%) patients on second repeat examination and 5 out of the 29 (17.2%) patients on third repeat examination were found to have ANs (P < 0.001).
CONCLUSION: Surveillance based on clear colonoscopy decreased the incidence of ANs in post-polypectomy patients. The number of repeat examinations required for a clear colonoscopy is an important factor in the prediction of the recurrence of ANs.

Entities:  

Keywords:  Adenoma; Incidence; Serrated polyp; Surveillance colonoscopy

Year:  2020        PMID: 32909200     DOI: 10.1007/s00464-020-07964-z

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  25 in total

1.  The first year follow-up after colorectal adenoma polypectomy is important: a multiple-center study in symptomatic hospital-based individuals in China.

Authors:  Qin-Yan Gao; Hui-Min Chen; Jian-Qiu Sheng; Ping Zheng; Cheng-Gong Yu; Bo Jiang; Jing-Yuan Fang
Journal:  Front Med China       Date:  2010-12-02

2.  Prevalence and predictors of interval colorectal cancers in medicare beneficiaries.

Authors:  Gregory S Cooper; Fang Xu; Jill S Barnholtz Sloan; Mark D Schluchter; Siran M Koroukian
Journal:  Cancer       Date:  2011-10-11       Impact factor: 6.860

3.  Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.

Authors:  N Jewel Samadder; Karen Curtin; Thérèse M F Tuohy; Lisa Pappas; Ken Boucher; Dawn Provenzale; Kerry G Rowe; Geraldine P Mineau; Ken Smith; Richard Pimentel; Anne C Kirchhoff; Randall W Burt
Journal:  Gastroenterology       Date:  2014-01-11       Impact factor: 22.682

4.  Interval cancers after negative colonoscopy: population-based case-control study.

Authors:  Hermann Brenner; Jenny Chang-Claude; Christoph M Seiler; Michael Hoffmeister
Journal:  Gut       Date:  2011-12-26       Impact factor: 23.059

5.  Colorectal cancers soon after colonoscopy: a pooled multicohort analysis.

Authors:  Douglas J Robertson; David A Lieberman; Sidney J Winawer; Dennis J Ahnen; John A Baron; Arthur Schatzkin; Amanda J Cross; Ann G Zauber; Timothy R Church; Peter Lance; E Robert Greenberg; María Elena Martínez
Journal:  Gut       Date:  2013-06-21       Impact factor: 23.059

6.  Postcolonoscopy colorectal cancers are preventable: a population-based study.

Authors:  Chantal M C le Clercq; Mariëlle W E Bouwens; Eveline J A Rondagh; C Minke Bakker; Eric T P Keulen; Rogier J de Ridder; Bjorn Winkens; Ad A M Masclee; Silvia Sanduleanu
Journal:  Gut       Date:  2013-06-06       Impact factor: 23.059

7.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.

Authors:  Ann G Zauber; Sidney J Winawer; Michael J O'Brien; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Benjamin F Hankey; Weiji Shi; John H Bond; Melvin Schapiro; Joel F Panish; Edward T Stewart; Jerome D Waye
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

8.  Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.

Authors:  Takuma Higurashi; Kunihiro Hosono; Hirokazu Takahashi; Yasuhiko Komiya; Shotaro Umezawa; Eiji Sakai; Takashi Uchiyama; Leo Taniguchi; Yasuo Hata; Shiori Uchiyama; Akiko Hattori; Hajime Nagase; Takaomi Kessoku; Jun Arimoto; Nobuyuki Matsuhashi; Yoshiaki Inayama; Shoji Yamanaka; Masataka Taguri; Atsushi Nakajima
Journal:  Lancet Oncol       Date:  2016-03-03       Impact factor: 41.316

9.  Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

Authors:  Cesare Hassan; Enrique Quintero; Jean-Marc Dumonceau; Jaroslaw Regula; Catarina Brandão; Stanislas Chaussade; Evelien Dekker; Mario Dinis-Ribeiro; Monika Ferlitsch; Antonio Gimeno-García; Yark Hazewinkel; Rodrigo Jover; Mette Kalager; Magnus Loberg; Christian Pox; Bjorn Rembacken; David Lieberman
Journal:  Endoscopy       Date:  2013-09-12       Impact factor: 10.093

Review 10.  Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature.

Authors:  S Sanduleanu; C M C le Clercq; E Dekker; G A Meijer; L Rabeneck; M D Rutter; R Valori; G P Young; R E Schoen
Journal:  Gut       Date:  2014-09-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.